Go to the list of all blogs
Allana's Avatar
published in Blogs
Feb 14, 2019
Exelixis (EXEL) earnings, revenues beat estimates in Q4 - Zacks

Exelixis (EXEL) earnings, revenues beat estimates in Q4 - Zacks

Exelixis, Inc. delivered better-than-expected results for fourth-quarter 2018, wherein both earnings and revenues beat estimates on strong performance by Cabometyx. 

Read more...

Related Ticker: EXEL

EXEL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for EXEL turned positive on June 29, 2026. Looking at past instances where EXEL's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 25, 2026. You may want to consider a long position or call options on EXEL as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EXEL advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 296 cases where EXEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EXEL broke above its upper Bollinger Band on July 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EXEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.667) is normal, around the industry mean (21.001). P/E Ratio (17.003) is within average values for comparable stocks, (36.006). Projected Growth (PEG Ratio) (2.618) is also within normal values, averaging (1.690). EXEL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (5.981) is also within normal values, averaging (368.009).

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.24B. The market cap for tickers in the group ranges from 58 to 132.55B. VRTX holds the highest valuation in this group at 132.55B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 12%, and the average quarterly price growth was 1,847%. CMMB experienced the highest price growth at 48%, while CRIS experienced the biggest fall at -97%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -55% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 81
Price Growth Rating: 52
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
EXEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
4600
Web
https://www.exelixis.com
Interact to see
Advertisement
TSM shares have remained relatively resilient despite heightened volatility, supported by the ongoing global buildout of AI infrastructure. Investor attention has centered on capacity expansion updates and signals from major customers, particularly in high-performance computing. While execution risks remain in the near term, leadership in advanced manufacturing and packaging continues to anchor TSM’s long-term growth narrative, even as global supply chains face scrutiny.
Rivian (RIVN) is carving out a distinct position in the electric vehicle market by targeting adventure-focused consumers, commercial fleets, and long-term sustainable transportation solutions. As the EV industry moves beyond early adoption toward scalability and efficiency, Rivian is emphasizing broader product offerings, streamlined manufacturing, and software-enabled services.
Aon plc (AON) reported third-quarter 2025 revenue of $3.997 billion, representing a 7% year-over-year increase with equal organic growth. Adjusted earnings per share came in at $3.05, exceeding expectations. In late November, Moody’s reaffirmed Aon’s Baa2 credit rating and revised the outlook to positive, citing reduced leverage following the NFP acquisition.
General Motors (GM) is in the midst of a long-term transformation, evolving from a traditional automotive manufacturer into a technology-focused mobility company. By combining its global scale, manufacturing capabilities, and well-known brands, GM is accelerating its push into electric vehicles, software-defined platforms, and autonomous systems, while continuing to generate cash from its internal-combustion portfolio.
Air Products and Chemicals, Inc. (APD) entered the spotlight after announcing advanced discussions with Yara International on December 8 to collaborate on low-emission ammonia projects. While the strategic direction aligns with global decarbonization trends, uncertainty around execution and capital requirements triggered a 9.45% one-day decline in the stock.
APO shares have traded in a relatively tight range recently, consolidating near the $148 level. The stock reflects investor confidence in Apollo’s expanding asset base, record fee earnings, and disciplined execution amid renewed interest in alternative assets. Growth in retirement services through Athene continues to provide stability, helping offset volatility across private equity and credit markets.
Lockheed Martin and RTX Corporation are two of the most prominent names in the aerospace and defense industry, both positioned to benefit from heightened global security concerns and sustained U.S. military spending.
Eli Lilly and Novo Nordisk are among the most influential pharmaceutical companies in the rapidly expanding GLP-1 receptor agonist market, which targets diabetes and obesity. As competition intensifies and regulatory and pricing dynamics evolve, the divergence in their stock performance has become increasingly pronounced.
Lumentum and Ciena are leading players in the optical networking sector, positioned to capitalize on surging demand for high-speed data transmission driven by AI, cloud computing, and 5G rollouts. Their business models, however, diverge significantly: LITE focuses on specialized photonic components, while CIEN offers broader networking solutions.
As 2025 winds down, the Savings Banks sector reflects a mix of stability, innovation, and AI-driven disruption. Among the most closely watched tickers—SOFI Technologies (SOFI), Ally Financial (ALLY), and PayPal Holdings (PYPL)—investors have witnessed contrasting stories of growth, valuation, and market perception.
As 2025 comes to a close, financial markets remain dynamic, with technology and entertainment stocks capturing investor attention. Streaming platforms, in particular, are navigating content consolidation, evolving consumer preferences, and digital monetization shifts. Netflix (NFLX), Disney (DIS), and Spotify (SPOT) stand out as major players at the intersection of streaming, entertainment, and technology.
Ondas Holdings (ONDS) is a wireless technology company focused on delivering secure, long-range communications for industrial Internet of Things (IoT) and data networking applications. Its solutions are built to support mission-critical operations across sectors such as rail, energy, maritime, infrastructure, and industrial automation.
Ciena’s growth is driven by expanding offerings in optical networking, network automation software, and 5G transport infrastructure, complemented by services designed to help customers modernize and future-proof their networks. Its evolving technology portfolio addresses the rising complexity, speed, and reliability requirements of today’s communications environment.
Marathon Digital Holdings (MARA) and Riot Platforms (RIOT) are two leading companies in the Bitcoin mining industry, each operating energy-intensive infrastructure to capitalize on cryptocurrency market cycles. This comparison is especially relevant amid ongoing Bitcoin price volatility and growing interest in digital assets and AI-related infrastructure.
Roivant Sciences has delivered strong year-to-date performance, with shares up roughly 82%, driven by encouraging pipeline developments and increased investment in high-potential subsidiaries such as Immunovant.
MP Materials Corp. (MP) and USA Rare Earth, Inc. (USAR) are central to the United States’ push to establish a secure, domestic supply of rare earth elements—materials critical to electric vehicles, renewable energy, and defense technologies. As geopolitical tensions and supply chain vulnerabilities intensify, these two companies offer distinct approaches to addressing U.S. dependence on foreign sources.
SanDisk (SNDK) Corporation has emerged as one of the strongest performers in the semiconductor storage space, benefiting from its central role in AI infrastructure buildouts. The stock has risen more than fivefold from recent cycle lows, fueled by accelerating demand for high-capacity NAND flash and solid-state drives essential for data-intensive workloads.
As markets move into 2026, the outlook for SPY remains cautiously optimistic. Technical momentum, investor sentiment, and AI-driven forecasts align in favor of continued upside, assuming macroeconomic conditions remain stable and Federal Reserve policy evolves as expected.
Over the past year, the Direxion Daily Semiconductor Bull 3X Shares ETF (SOXL) has stood out as one of the market’s most volatile—and potentially rewarding—leveraged ETFs. Designed to deliver three times the daily performance of the ICE Semiconductor Index, SOXL closely tracks the heartbeat of the semiconductor industry, a sector at the core of global digital and AI transformation.